cliffwatch

Applicant, as named in the Orange Book

Incyte Corp

Next listed expiry: Jakafi on 22 Mar 2029. 4 products with live protection, 0 without.

Products with listed protection

DrugEarliest generic entry
Jakafi · 5 strengths
ruxolitinib phosphate
22 Mar 2029
Jakafi Xr · 5 strengths
ruxolitinib phosphate
17 Jul 2034
Pemazyre · 3 strengths
pemigatinib
3 Oct 2040
Opzelura
ruxolitinib phosphate
5 May 2041

Recent events

  • 25 Oct 2026Pemazyre · Generic tentatively approved
  • 24 Oct 2026Jakafi · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jakafi · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jakafi · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jakafi · Exclusivity expires within 90 days PED
  • 24 Oct 2026Jakafi · Exclusivity expires within 90 days PED